Understanding how eEF2K regulates protein synthesis in cells
Molecular Mechanisms of Translation Regulation by the eEF2K Pathway
This study is looking at how a specific protein called eEF2K helps control how cells make other proteins, which is important for understanding diseases like cancer and autoimmune disorders, and it’s aimed at anyone interested in how our cells work.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Santa Cruz NIH-funded |
| Lab location | 1 site (Santa Cruz, United States) |
| Project ID | NIH-10928160 on NIH RePORTER |
What this research studies
This research investigates the molecular mechanisms by which eukaryotic elongation factor 2 kinase (eEF2K) regulates protein synthesis in cells. It aims to create a detailed model of how eEF2K interacts with ribosomes and influences the translation of specific mRNAs, particularly in response to various cellular signals. By examining the phosphorylation of eEF2 and its effects on ribosome activity, the research seeks to uncover the underlying processes that control protein production in different cell types, including neurons. This could lead to insights into how disruptions in these processes contribute to diseases such as cancer and autoimmune disorders.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals affected by neurological disorders, cancers, or autoimmune diseases.
Not a fit: Patients with conditions unrelated to protein synthesis regulation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for treating diseases linked to dysfunctional protein synthesis.
How similar studies have performed: Previous research has shown promising results in understanding translation regulation, suggesting that this approach could yield valuable insights.
Where this research is happening
Santa Cruz, United States
- University of California Santa Cruz — Santa Cruz, United States (Active)
Researchers
- Principal investigator: Loerch, Sarah — University of California Santa Cruz
- Study coordinator: Loerch, Sarah
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.